{"id":"W4401805922","doi":"10.1007/s12185-024-03834-9","title":"Tazemetostat for relapsed/refractory B-cell non-Hodgkin lymphoma with EZH2 mutation in Japan: 3-year follow-up for a phase II study","year":2024,"lang":"en","type":"article","venue":"International Journal of Hematology","topic":"Lymphoma Diagnosis and Treatment","field":"Medicine","cited_by":8,"is_retracted":false,"has_abstract":true,"ca_institutions":"","funders":"Eisai Canada; Eisai","keywords":"Medicine; Internal medicine; Adverse effect; Cohort; Refractory (planetary science); Gastroenterology; Lymphoma; Oncology","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[{"model":"gemma","categories":[],"domain":null,"study_design":"nonrandomized_trial","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"},{"model":"gpt","categories":[],"domain":null,"study_design":"design_other","genre":"empirical","about_ca_system":false,"about_ca_topic":false,"confidence":"low","status":"direct model label, unvalidated"}],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.000307926,0.0001693692,0.0004627053,0.0005191377,0.00004095913,0.00003628591,0.0001407456,0.00008003457,0.00004159695],"category_scores_gemma":[0.0001289795,0.0001213229,0.0002082733,0.0001113418,0.00003416071,0.0001771448,0.00002566788,0.00008721405,0.000008300902],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003657764,"about_ca_system_score_gemma":0.0004120856,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00002728161,"about_ca_topic_score_gemma":0.0000663738,"domain_scores_codex":[0.9985633,0.00003063396,0.0006286687,0.0002311229,0.0003552549,0.0001909874],"domain_scores_gemma":[0.9985678,0.0004791888,0.000260602,0.0001036701,0.0005010792,0.0000876878],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.1018895,0.09191912,0.2033553,0.001303842,0.01381199,0.03233359,0.02877554,0.0001822102,0.006420777,0.01593837,0.05019804,0.4538717],"study_design_scores_gemma":[0.5633557,0.2576353,0.0233607,0.003312357,0.003048752,0.02287375,0.01359716,0.006071533,0.03980789,0.003871153,0.06209793,0.0009677726],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9926329,0.0007467582,0.002089542,0.002060166,0.001323995,0.0009319565,0.00004242671,0.00001422229,0.0001580824],"genre_scores_gemma":[0.9965048,0.00004105227,0.00244998,0.0001908847,0.0002161956,0.0001948962,0.00004638238,0.00003184943,0.0003239963],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.4614662,"threshold_uncertainty_score":0.4947406,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01632198740253884,"score_gpt":0.3324388202306839,"score_spread":0.3161168328281451,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}